Simplex Trading’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-400
| Closed | -$1K | – | 9866 |
|
|
2023
Q3 | $1K | Hold |
400
| – | – | ﹤0.01% | 8435 |
|
|
2023
Q2 | $1K | Sell |
400
-2,100
| -84% | -$8.24K | ﹤0.01% | 8740 |
|
|
2023
Q1 | $9K | Sell |
2,500
-210,100
| -99% | -$1.01M | ﹤0.01% | 7661 |
|
|
2022
Q4 | $1.19M | Sell |
212,600
-8,400
| -4% | -$49.5K | ﹤0.01% | 2307 |
|
|
2022
Q3 | $1.47M | Sell |
221,000
-2,400
| -1% | -$19.4K | ﹤0.01% | 2260 |
|
|
2022
Q2 | $2.22M | Buy |
223,400
+223,322
| +286,310% | +$2.13M | ﹤0.01% | 1770 |
|
|
2022
Q1 | $1K | Sell |
78
-166
| -68% | -$2.61K | ﹤0.01% | 10158 |
|
|
2021
Q4 | $4K | Sell |
244
-638
| -72% | -$19.1K | ﹤0.01% | 9717 |
|
|
2021
Q3 | $53K | Sell |
882
-156
| -15% | -$6.92K | ﹤0.01% | 7453 |
|
|
2021
Q2 | $61K | Buy |
+1,038
| New | +$62.9K | ﹤0.01% | 7413 |
|
|
2021
Q1 | – | Sell |
-2
| Closed | -$11K | – | 10073 |
|
|
2020
Q4 | $11K | Buy |
2
+1
| +100% | +$68 | ﹤0.01% | 7370 |
|
|
2020
Q3 | $8K | Sell |
1
-4
| -80% | -$319 | ﹤0.01% | 6915 |
|
|
2020
Q2 | $28K | Buy |
5
+4
| +400% | +$233 | ﹤0.01% | 5973 |
|
|
2020
Q1 | $7K | Sell |
1
-1
| -50% | -$99 | ﹤0.01% | 6695 |
|
|
2019
Q4 | $20K | Sell |
2
-4
| -67% | -$575 | ﹤0.01% | 5957 |
|
|
2019
Q3 | $108K | Buy |
6
+5
| +500% | +$705 | ﹤0.01% | 4247 |
|
|
2019
Q2 | $13K | Sell |
1
-7
| -88% | -$1.25K | ﹤0.01% | 5960 |
|
|
2019
Q1 | $201K | Buy |
8
+6
| +300% | +$1.59K | ﹤0.01% | 3608 |
|
|
2018
Q4 | $41K | Sell |
2
-2
| -50% | -$488 | ﹤0.01% | 4730 |
|
|
2018
Q3 | $140K | Buy |
4
+1
| +33% | +$306 | ﹤0.01% | 4061 |
|
|
2018
Q2 | $95K | Hold |
3
| – | – | ﹤0.01% | 4355 |
|
|
2018
Q1 | $20K | Buy |
3
+2
| +200% | +$561 | ﹤0.01% | 3376 |
|
|
2017
Q4 | $10K | Hold |
1
| – | – | ﹤0.01% | 3916 |
|
|
2017
Q3 | $11K | Buy |
+1
| New | +$289 | ﹤0.01% | 3706 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 5749 |
|
|
2017
Q1 | – | Sell |
-7
| Closed | -$61K | – | 6806 |
|
|
2016
Q4 | $61K | Buy |
+7
| New | +$2.17K | ﹤0.01% | 1969 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$365 | – | 4739 |
|
|
2016
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 5022 |
|
|
2016
Q1 | $7K | Sell |
1
-5
| -83% | -$1.71K | ﹤0.01% | 3833 |
|
|
2015
Q4 | $9K | Buy |
6
+4
| +200% | +$1.48K | ﹤0.01% | 3419 |
|
|
2015
Q3 | $15K | Buy |
2
+1
| +100% | +$355 | ﹤0.01% | 3084 |
|
|
2015
Q2 | $4K | Buy |
+1
| New | +$353 | ﹤0.01% | 3881 |
|
|
2015
Q1 | – | Hold |
0
| – | -$1K | – | 5615 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 4295 |
|
Other funds holding TXMD
RCMNY
CC
SCM
VCM
TC
ACM
Simplex Trading's TXMD Position: Q3 2025 in Review
Simplex Trading sold out of TherapeuticsMD (TXMD) in Q3 2025, closing a stake of 428 shares — an estimated $480 sold.
Simplex Trading first reported a position in TXMD in Q2 2015 and held it in 18 quarters. The position peaked at $273K in Q3 2018. 46 funds tracked by Wall St. Rank hold TXMD as of Q3 2025.
- Simplex Trading reported no remaining TherapeuticsMD position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 428 TherapeuticsMD shares in Q3 2025, an estimated $480.
- Simplex Trading first reported a position in TherapeuticsMD in Q2 2015 and held it in 18 quarters.
- Simplex Trading's TherapeuticsMD position peaked at $273K in Q3 2018.
- 46 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.